Certified by Founder Lodge
Coave Therapeutics
France - PARIS
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 09 ,2025 | Series A | $32,000,000 |
Omnes
UI Investissement
Turenne Groupe
Kurma Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
